Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Avoro Capital Advisors LLC reported a 6.10% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Avoro Capital Advisors LLC reported a 6.10% stake in Monte Rosa Therapeutics, Inc., 3,725,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 6.10%
- Shares
- 3,725,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avoro Capital Advisors LLC | 6.10% | 3,725,000 |
| Behzad Aghazadeh | 6.10% | 3,725,000 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Avoro Capital Advisors LLC
- Monte Rosa Therapeutics, Inc. shareholders
- Schedule 13G/A · Avoro Capital Advisors LLC · Nov 14, 2025
- Schedule 13G/A · Avoro Capital Advisors LLC · Feb 14, 2025
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026